Adam Monsalve

Title: Adam Monsalve: Innovator in Growth Factor Control

Introduction

Adam Monsalve is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of tissue engineering and regenerative medicine through his innovative research and patents.

Latest Patents

Monsalve holds a patent for "Controlling the activity of growth factors, particularly TGF-β, in vivo." This patent involves the conjugation of TGF-β growth factor and its latent complex to magnetic micro- or nanoparticles and to magnetic micro- or nanodiscs. By exposing these conjugates to magnetic fields, the TGF-β growth factor can be released from its latent complex in vivo. This technology has the potential to be useful in tissue engineering and regenerative medicine. Furthermore, by applying a sufficiently strong radiofrequency magnetic field to a conjugate of TGF-β growth factor and a magnetic particle, the TGF-β growth factor can be denatured and deactivated. This capability may help avoid triggering tumorigenesis, atherosclerosis, fibrotic disease, and cancer.

Career Highlights

Monsalve is affiliated with the University of Florida Research Foundation, Incorporated, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in medical science.

Collaborations

Monsalve collaborates with Jon Paul Dobson, contributing to the advancement of their shared research interests.

Conclusion

Adam Monsalve is a pioneering inventor whose work in controlling growth factors has the potential to revolutionize tissue engineering and regenerative medicine. His innovative approaches and patents reflect his commitment to advancing medical science.